Skip to main content
. 2021 May 20;10(5):1269. doi: 10.3390/cells10051269

Table 2.

Molecules involved in T cell migration through afferent LVs to dLNs.

Molecule Comments References
CCR7/CCL21 In mice, Ccr7−/− T cells display a profound reduction in migration from peripheral tissues to dLNs.
In humans, all recirculating memory T cell subtypes are CCR7+
[41]
[147]
S1P Treatment with FTY720 reduced T cell migration to LNs
Blocking of S1P1 and S1P4 reduce entry of Teff CD4+ into afferent LVs
S1P2 in LECs regulates T cell motility and transmigration
[82]
[162]
[162]
CD44/Macrophage mannose receptor (MMR) Interaction of MMR in LECs with CD44 in T cells mediates CD4+ and CD8+ egress from skin [169,170]
CLEVER-1 CLEVER-1 blockade reduces CD4+ and CD8+ T cell migration from the skin to the dLN [171,172]
ICAM-1/VCAM-1 T cells require LFA-1/ICAM-1 interactions promoting T cell crawling and overall migration through afferent LVs
Treg migration to dLNs depends on VCAM-1
TH1 cell migration to dLNs depends on VCAM-1
[65]
[65,152]
Lymphotoxin (LT) Blockade of LTBR that binds to VCAM-1 reduced Treg exit from the skin
Treg modulate LECs for transmigration of other cells, by stimulating LEC LTBR, to increase VCAM-1 and CCL21
[48]
CD69 CD69 downregulates S1P1, thereby inhibiting T cell egress from skin
Cd69-/- T cells can enter the skin but do not form a TRM population
[166]
[165]
MECA-32 (PLVAP) PLVAP expressed by LN LECs mediates lymphocyte entry across the subcapsular sinus into the LN parenchyma [30]